08/31/2026
Eight years ago, PBG BioPharma was founded by Dr. Jacqueline Shan with a clear goal: to build a pharmaceutical-standard cannabinoid company based on science, quality, and innovation.
The journey has not been easy. The industry has gone through market shifts, regulatory complexity, COVID-19, financial pressure, and the challenges of building in a young and evolving sector.
Through it all, our focus has remained the same.
We believe the future of cannabinoids is not about commodity products or short-term trends. It is about rigorous science, strong quality systems, GMP manufacturing, and long-term healthcare value.
Every challenge has made that direction clearer.
Today, PBG BioPharma continues to build for the long term, with science, innovation, quality, and responsible cannabinoid development at the core of what we do.